Research on D-chiro-inositol for blood sugar regulation is not directly supported by the single study provided, which focuses on myo-inositol — a related but distinct compound — during pregnancy in women with PCOS. The available evidence here consists of a registered trial protocol rather than completed research, meaning no results have yet been reported from this work. Studies indicate that earlier trials on myo-inositol showed promise for reducing gestational diabetes risk in broader pregnant populations, with the current protocol designed to test whether those benefits extend specifically to women with PCOS, but this does not speak directly to the effects of D-chiro-inositol on blood sugar regulation in the general population. Readers should be aware that the evidence base provided for this specific question is quite limited, and drawing conclusions about D-chiro-inositol from this single protocol would not be well-supported by the research presented.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| MYPP trial: Myo-inositol supplementation to prevent pregnancy complications i... | Other | 2025 | Neutral | 90 |